PHI PHARMA SA
3Patents
3Active
3Granted
42Portfolio score
Filing activity: Nov 7, 2013 → Apr 27, 2015
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10131690B2 | C6S specific transporter molecules | Emerging Cross-Sectional Technologies | 12 | Active |
| US9688723B2 | C4S proteoglycan specific transporter molecules | Emerging Cross-Sectional Technologies | 1 | Active |
| US10174078B2 | Keratan sulfate specific transporter molecules | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.